Human Papilloma Virus: Combatting Cancer with Vaccination
Keywords:
Human Papilloma Virus (HPV), Vaccination, Viral Pathogenesis, CancerAbstract
Human papilloma virus (HPV) is the only virus responsible for cancer progression, as it has been directly associated with the development of cervical cancer. HPV positive tumours have also been found in oral cavities creating a rise in head and neck cancers. Recently, a vaccine has been developed that is highly effective at preventing the pathogenesis of HPV and HPV-related cancers. This article aims to review the basic progression of HPV in the body, and expand on the newfound dangers associated with this prevalent sexually transmitted disease.
References
Bernard, X.,, Robinson, P.,, Nominé, Y.,, Masson, M., and Brutscher, B., 2011. Proteasomal Degradation of p53 by Human Papillomavirus E6 Oncoprotein Relies on the Structural Integrity of p53 Core Domain. PLoS ONE, [online] 6(10), p.e25981. Available at: <http://dx.plos.org/10.1371/journal.pone.0025981> [Accessed 25 Jan. 2017].
Brotherton, J.M.,, Fridman, M.,, May, C.L.,, Chappell, G.,, Saville, A.M., and Gertig, D.M., 2011. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet, 377(9783), pp.2085–2092.
Burd, E.M., 2003. Human papillomavirus and cervical cancer. Clinical microbiology reviews, [online] 16(1), pp.1–17. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/12525422> [Accessed 26 Jan. 2017].
Doorbar, J.,, Egawa, N.,, Griffin, H.,, Kranjec, C., and Murakami, I., 2015. Human papillomavirus molecular biology and disease association. Reviews in Medical Virology, [online] 25(S1), pp.2–23. Available at: <http://doi.wiley.com/10.1002/rmv.1822> [Accessed 26 Jan. 2017].
Hawley-Nelson, P.,, Vousden, K.,, Hubbert, N.,, Lowy, D., and Schiller, J., 1989. HPV 16: E6 and E7 protiens cooperate to immortalize human foreskin keratinocytes. EMBO Journal, 8(12), pp.3905–3910.
Hebner, C.M., and Laimins, L.A., 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Reviews in Medical Virology, [online] 16(2), pp.83–97. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/16287204> [Accessed 5 Mar. 2017].
Kimple, R.J., and Harari, P.M., 2015. The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy. Annals of translational medicine, [online] 3(Suppl 1), p.S14. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/26046059> [Accessed 26 Feb. 2017].
Longworth, M.S., and Laimins, L.A., 2004. Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiology and Molecular Biology Reviews, [online] 68(2), pp.362–372. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/15187189> [Accessed 26 Feb. 2017].
Marur, S.,, D’Souza, G.,, Westra, W.H., and Forastiere, A.A., 2010. HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology, 11(8), pp.781–789.
Molano, M.,, van den Brule, A.,, Plummer, M.,, Weiderpass, E.,, Posso, H.,, Arslan, A.,, Meijer, C.J.L.M.,, Muñoz, N., and Franceschi, S., 2003. Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study. American Journal of Epidemiology, [online] 158(5), pp.486–494. Available at: <https://academic.oup.com/aje/article-lookup/doi/10.1093/aje/kwg171> [Accessed 26 Feb. 2017].
Münger, K.,, Baldwin, A.,, Edwards, K.M.,, Hayakawa, H.,, Nguyen, C.L.,, Owens, M.,, Grace, M., and Huh, K., 2004. Mechanisms of human papillomavirus-induced oncogenesis. Journal of virology, [online] 78(21), pp.11451–60. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/15479788> [Accessed 15 Jan. 2017].
National Cancer Institute, 2016. Human papillomavirus (HPV) vaccines. U.S Department of Health and Human Services.
Oh, S.T.,, Kyo, S., and Laimins, L.A., 2001. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. Journal of virology, [online] 75(12), pp.5559–66. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/11356963> [Accessed 26 Jan. 2017].
Public Health Agency of Canada, 2015. Human papillomavirus (HPV) prevention and HPV vaccines: questions and answers.
Scott, M.E.,, Shvetsov, Y.B.,, Thompson, P.J.,, Hernandez, B.Y.,, Zhu, X.,, Wilkens, L.R.,, Killeen, J.,, Vo, D.D.,, Moscicki, A.-B., and Goodman, M.T., 2013. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. International journal of cancer, [online] 133(5), pp.1187–96. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/23436563> [Accessed 26 Feb. 2017].
Thorland, E.C.,, Myers, S.L.,, Gostout, B.S., and Smith, D.I., 2003. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene, [online] 22(8), pp.1225–1237. Available at: <http://www.nature.com/doifinder/10.1038/sj.onc.1206170> [Accessed 25 Jan. 2017].
Wang, S.S.,, Zuna, R.E.,, Wentzensen, N.,, Dunn, S.T.,, Sherman, M.E.,, Gold, M.A.,, Schiffman, M.,, Wacholder, S.,, Allen, R.A.,, Block, I.,, Downing, K.,, Jeronimo, J.,, Carreon, J.D.,, Safaeian, M.,, Brown, D., and Walker, J.L., 2009. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, [online] 18(1), pp.113–20. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/19124488> [Accessed 29 Jan. 2017].
Watson, R.A., 2005. Human Papillomavirus: Confronting the Epidemic-A Urologist’s Perspective. Reviews in urology, [online] 7(3), pp.135–44. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/16985824> [Accessed 26 Feb. 2017].
Williams, V.M.,, Filippova, M.,, Soto, U., and Duerksen-Hughes, P.J., 2011. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future virology, [online] 6(1), pp.45–57. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/21318095> [Accessed 25 Jan. 2017].
Workowiski, K., and Berman, S., 2010. Sexually Transmitted Diseases Treatment Guidelines, 2010.
Yim, E.-K., and Park, J.-S., 2005. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer research and treatment : official journal of Korean Cancer Association, [online] 37(6), pp.319–24. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/19956366> [Accessed 26 Jan. 2017].
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).